Ohio Startup Bolstering Supply For Potential COVID-19 Clinical Trial

An Ohio-based biotech continues to work "around the clock" to advance its protein replacement therapy as a potential treatment for the novel coronavirus – including a new collaboration with a European-based manufacturer to boost supply, while also taking the first steps toward clinical trials with the Food & Drug Administration.